Skip to main content
Erschienen in: Journal of Clinical Immunology 1/2010

01.01.2010

Differential Deposition of C4d and MBL in Glomeruli of Patients with ANCA-Negative Pauci-Immune Crescentic Glomerulonephritis

verfasst von: Guang-qun Xing, Min Chen, Gang Liu, Xin Zheng, Jie E, Ming-hui Zhao

Erschienen in: Journal of Clinical Immunology | Ausgabe 1/2010

Einloggen, um Zugang zu erhalten

Abstract

Objective

Our previous study suggested involvement of alternative pathway activation of complement in ANCA-positive pauci-immune crescentic glomerulonephritis (CrGN). This study was to investigate the evidence of complement activation in renal biopsy specimens of patients with ANCA-negative pauci-immune CrGN.

Methods

Renal biopsy specimens from 12 patients with ANCA-negative pauci-immune CrGN were used to detect the staining of membrane attack complex (MAC), C3d, C4d, mannose-binding lectin (MBL), factor B by immunohistochemistry, and/or immunofluorescence. Renal tissue from eight patients with minimal change disease (MCD) and renal tissue obtained from a normal kidney and the normal parts of a nephrectomized kidney due to renal carcinoma was used as disease and normal controls, respectively.

Results

MAC and C3d could be detected in the active renal lesions of cellular crescents in each of the 12 ANCA-negative CrGN patients but not or scarcely detected in patients with MCD and in normal renal tissue. The deposition of other complement components in the 12 patients was heterogeneous. Although none of them had C1q staining, eight of the 12 were C4d positive and six out of the eight were MBL positive. The remaining four only had evidence of the alternative pathway activation by positive staining of C3d, factor B, and MAC. The staining intensity of C4d and MBL was much higher in dialysis-dependent patients than that in dialysis-independent patients.

Conclusion

Complement activation was involved in renal damage of human ANCA-negative pauci-immune CrGN but with heterogeneous activation pathways. Positive staining of C4d and MBL might be associated with poor renal outcome.
Literatur
1.
Zurück zum Zitat Jennette JC. Rapidly progressive crescentic glomerulonephritis. Kidney Int. 2003;63:1164–77.CrossRefPubMed Jennette JC. Rapidly progressive crescentic glomerulonephritis. Kidney Int. 2003;63:1164–77.CrossRefPubMed
2.
Zurück zum Zitat Falk RJ, Jennette JC. ANCA small-vessel vasculitis. J Am Soc Nephrol. 1997;8:314–22.PubMed Falk RJ, Jennette JC. ANCA small-vessel vasculitis. J Am Soc Nephrol. 1997;8:314–22.PubMed
3.
Zurück zum Zitat Harris AA, Falk RJ, Jennette JC. Crescentic glomerulonephritis with a paucity of glomerular immunoglobulin localization. Am J Kidney Dis. 1998;32:179–84.CrossRefPubMed Harris AA, Falk RJ, Jennette JC. Crescentic glomerulonephritis with a paucity of glomerular immunoglobulin localization. Am J Kidney Dis. 1998;32:179–84.CrossRefPubMed
4.
Zurück zum Zitat Short AK, Esnault VL, Lockwood CM. Anti-neutrophil cytoplasmic antibodies and anti-glomerular basement membrane antibodies: Two coexisting distinct autoreactivities detectable in patients with rapidly progressive glomerulonephritis. Am J Kidney Dis. 1995;26:439–45.CrossRefPubMed Short AK, Esnault VL, Lockwood CM. Anti-neutrophil cytoplasmic antibodies and anti-glomerular basement membrane antibodies: Two coexisting distinct autoreactivities detectable in patients with rapidly progressive glomerulonephritis. Am J Kidney Dis. 1995;26:439–45.CrossRefPubMed
5.
Zurück zum Zitat Xiao H, Heeringa P, Hu P, Liu Z, Zhao M, Aratani Y, et al. Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest. 2002;110:955–63.PubMed Xiao H, Heeringa P, Hu P, Liu Z, Zhao M, Aratani Y, et al. Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest. 2002;110:955–63.PubMed
6.
Zurück zum Zitat Xiao H, Schreiber A, Heeringa P. Alternative complement pathway in the pathogenesis of disease mediated by antineutrophil cytoplasmic autoantibodies. Am J Pathol. 2007;170:52–64.CrossRefPubMed Xiao H, Schreiber A, Heeringa P. Alternative complement pathway in the pathogenesis of disease mediated by antineutrophil cytoplasmic autoantibodies. Am J Pathol. 2007;170:52–64.CrossRefPubMed
7.
Zurück zum Zitat Huugen D, Esch AV, Xiao H, Peutz-kootstra CJ, Buuman WA, Tervaert JW, et al. Inhibition of complement factor C5 protects against anti-myeloperoxidase antibody-mediated glomerulonephritis in mice. Kidney Int. 2007;71:646–54.CrossRefPubMed Huugen D, Esch AV, Xiao H, Peutz-kootstra CJ, Buuman WA, Tervaert JW, et al. Inhibition of complement factor C5 protects against anti-myeloperoxidase antibody-mediated glomerulonephritis in mice. Kidney Int. 2007;71:646–54.CrossRefPubMed
8.
Zurück zum Zitat Schreiber A, Xiao H, Jennette JC, Schneider W, Luft FC, Kettritz R. C5a receptor mediates neutrophil activation and ANCA-induced glomerulonephritis. J Am Soc Nephrol. 2009;20:289–98.CrossRefPubMed Schreiber A, Xiao H, Jennette JC, Schneider W, Luft FC, Kettritz R. C5a receptor mediates neutrophil activation and ANCA-induced glomerulonephritis. J Am Soc Nephrol. 2009;20:289–98.CrossRefPubMed
9.
Zurück zum Zitat Chen M, Xing GQ, Yu F, Liu G, Zhao MH. Complement deposition in renal histopathology of patients with ANCA-associated pauci-immune glomerulonephritis. Nephrol Dial Transplant. 2009;24:1247–52.CrossRefPubMed Chen M, Xing GQ, Yu F, Liu G, Zhao MH. Complement deposition in renal histopathology of patients with ANCA-associated pauci-immune glomerulonephritis. Nephrol Dial Transplant. 2009;24:1247–52.CrossRefPubMed
10.
Zurück zum Zitat Xing GQ, Chen M, Liu G, Heeringa P, Zhang JJ, Zheng X. E J, Kallenberg CG, Zhao MH. Complement activation is involved in renal damage in human antineutrophil cytoplasmic autoantibody associated pauci-immune vasculitis. J Clin Immunol. 2009;29:282–91.CrossRefPubMed Xing GQ, Chen M, Liu G, Heeringa P, Zhang JJ, Zheng X. E J, Kallenberg CG, Zhao MH. Complement activation is involved in renal damage in human antineutrophil cytoplasmic autoantibody associated pauci-immune vasculitis. J Clin Immunol. 2009;29:282–91.CrossRefPubMed
11.
Zurück zum Zitat Hedger N, Stevens J, Drey N, Walker S, Roderick P. Incidence and outcome of pauci-immune rapidly progressive glomerulonephritis in Wessex, UK: a 10-year retrospective study. Nephrol Dial Transplant. 2000;15:1593–99.CrossRefPubMed Hedger N, Stevens J, Drey N, Walker S, Roderick P. Incidence and outcome of pauci-immune rapidly progressive glomerulonephritis in Wessex, UK: a 10-year retrospective study. Nephrol Dial Transplant. 2000;15:1593–99.CrossRefPubMed
12.
Zurück zum Zitat Hung PH, Chiu YL, Lin WC, Chiang WC, Chen YM, Lin SL, et al. Poor renal outcome of antineutrophil cytoplasmic antibody negative pauci-immune glomerulonephritis in Taiwanese. J Formos Med Assoc. 2006;105:804–12.CrossRefPubMed Hung PH, Chiu YL, Lin WC, Chiang WC, Chen YM, Lin SL, et al. Poor renal outcome of antineutrophil cytoplasmic antibody negative pauci-immune glomerulonephritis in Taiwanese. J Formos Med Assoc. 2006;105:804–12.CrossRefPubMed
13.
Zurück zum Zitat Chen M, Yu F, Wang SX, Zou WZ, Zhao MH, Wang HY. Antineutrophil cytoplasmic autoantibody negative pauci-immune crescentic glomerulonephritis. J Am Soc Nephrol. 2007;18:599–605.CrossRefPubMed Chen M, Yu F, Wang SX, Zou WZ, Zhao MH, Wang HY. Antineutrophil cytoplasmic autoantibody negative pauci-immune crescentic glomerulonephritis. J Am Soc Nephrol. 2007;18:599–605.CrossRefPubMed
14.
Zurück zum Zitat Zhao MH, Lockwood CM. A comprehensive method to purify three major ANCA antigens: proteinase 3, myeloperoxidase and bactericidal/permeability-increasing protein from human neutrophil granule acid extract. J Immunol Methods. 1996;197:121–30.CrossRefPubMed Zhao MH, Lockwood CM. A comprehensive method to purify three major ANCA antigens: proteinase 3, myeloperoxidase and bactericidal/permeability-increasing protein from human neutrophil granule acid extract. J Immunol Methods. 1996;197:121–30.CrossRefPubMed
15.
Zurück zum Zitat Sacks SH, Zhou W. New boundaries for complement in renal disease. J Am Soc Nephrol. 2008;19:1865–69.CrossRefPubMed Sacks SH, Zhou W. New boundaries for complement in renal disease. J Am Soc Nephrol. 2008;19:1865–69.CrossRefPubMed
16.
Zurück zum Zitat Shi XY, Hou FF, Niu HX, Wang GB, Xie D, Guo ZJ, et al. Advanced oxidation protein products promote inflammation in diabetic kidney through activation of renal nicotinamide adenine dinucleotide phosphate oxidase. Endocrinology. 2008;149:1829–39.CrossRefPubMed Shi XY, Hou FF, Niu HX, Wang GB, Xie D, Guo ZJ, et al. Advanced oxidation protein products promote inflammation in diabetic kidney through activation of renal nicotinamide adenine dinucleotide phosphate oxidase. Endocrinology. 2008;149:1829–39.CrossRefPubMed
17.
Zurück zum Zitat Jennette JC, Thomas DB. Pauci-immune and antineutrophil cytoplasmic autoantibody associated crescentic glomerulonephritis and vasculitis. In: Jennette JC, Olson JL, Schwartz MM, Silva FG, editors. Hepinstall’s pathology of the kidney. 6th ed. Philadelphia: Lippincott Williams and Wilkins; 2007. p. 644. Jennette JC, Thomas DB. Pauci-immune and antineutrophil cytoplasmic autoantibody associated crescentic glomerulonephritis and vasculitis. In: Jennette JC, Olson JL, Schwartz MM, Silva FG, editors. Hepinstall’s pathology of the kidney. 6th ed. Philadelphia: Lippincott Williams and Wilkins; 2007. p. 644.
18.
Zurück zum Zitat Haas M, Eustace JA. Immune complex deposits in ANCA-associated crescentic glomerulonephritis: a study of 126 cases. Kidney Int. 2004;65:2145–52.CrossRefPubMed Haas M, Eustace JA. Immune complex deposits in ANCA-associated crescentic glomerulonephritis: a study of 126 cases. Kidney Int. 2004;65:2145–52.CrossRefPubMed
19.
Zurück zum Zitat Neumann I, Regele H, Kain R, Birck R, Meis FT. Glomerular immune deposits are associated with increased proteinuria in patients with ANCA-associated crescentic nephritis. Nephrol Dial Transplant. 2003;18:524–31.CrossRefPubMed Neumann I, Regele H, Kain R, Birck R, Meis FT. Glomerular immune deposits are associated with increased proteinuria in patients with ANCA-associated crescentic nephritis. Nephrol Dial Transplant. 2003;18:524–31.CrossRefPubMed
20.
Zurück zum Zitat Yu F, Chen M, Gao Y, Wang SX, Zou WZ, Zhao MH, et al. Clinical and pathological features of renal involvement in propylthiouracil-associated ANCA-positive vasculitis. Am J Kidney Dis. 2007;49:607–14.CrossRefPubMed Yu F, Chen M, Gao Y, Wang SX, Zou WZ, Zhao MH, et al. Clinical and pathological features of renal involvement in propylthiouracil-associated ANCA-positive vasculitis. Am J Kidney Dis. 2007;49:607–14.CrossRefPubMed
21.
Zurück zum Zitat Chen M, Kallenberg CGM, Zhao MH. ANCA-negative pauci-immune crescentic glomerulonephritis. Nat Rev Nephrol. 2009;5:313–8.CrossRefPubMed Chen M, Kallenberg CGM, Zhao MH. ANCA-negative pauci-immune crescentic glomerulonephritis. Nat Rev Nephrol. 2009;5:313–8.CrossRefPubMed
22.
Zurück zum Zitat Wang F, Chen M, Zhao MH. Circulating neutrophil degranulation is involved in ANCA-negative pauci-immune crescentic glomerulonephritis. J Nephrol. 2009;22:491–6.PubMed Wang F, Chen M, Zhao MH. Circulating neutrophil degranulation is involved in ANCA-negative pauci-immune crescentic glomerulonephritis. J Nephrol. 2009;22:491–6.PubMed
23.
Zurück zum Zitat Cong M, Chen M, Zhang JJ, Hu Z, Zhao MH. Anti-endothelial cell antibodies in antineutrophil cytoplasmic antibodies negative pauci-immune crescentic glomerulonephritis. Nephrology (Carlton). 2008;13:228–34.CrossRef Cong M, Chen M, Zhang JJ, Hu Z, Zhao MH. Anti-endothelial cell antibodies in antineutrophil cytoplasmic antibodies negative pauci-immune crescentic glomerulonephritis. Nephrology (Carlton). 2008;13:228–34.CrossRef
24.
Zurück zum Zitat Sahu A, Lambris JD. Structure and biology of complement protein C3, a connecting link between innate and acquired immunity. Immunol Rev. 2001;180:35–48.CrossRefPubMed Sahu A, Lambris JD. Structure and biology of complement protein C3, a connecting link between innate and acquired immunity. Immunol Rev. 2001;180:35–48.CrossRefPubMed
25.
Zurück zum Zitat Schulze M, Pruchno CJ, Burns M, Baker PJ, Johnson RJ, Couser WG. Glomerular C3c localization indicates ongoing immune deposit formation and complement activation in experimental glomerulonephritis. Am J Pathol. 1993;142:179–87.PubMed Schulze M, Pruchno CJ, Burns M, Baker PJ, Johnson RJ, Couser WG. Glomerular C3c localization indicates ongoing immune deposit formation and complement activation in experimental glomerulonephritis. Am J Pathol. 1993;142:179–87.PubMed
26.
Zurück zum Zitat Chakravarti DN, Campbell RD, Porter RR. The chemical structure of the C4d fragment of the human complement component C4. Mol Immunol. 1987;24:1187–97.CrossRefPubMed Chakravarti DN, Campbell RD, Porter RR. The chemical structure of the C4d fragment of the human complement component C4. Mol Immunol. 1987;24:1187–97.CrossRefPubMed
27.
Zurück zum Zitat Hisano S, Matsushita M, Fujita T, Endo Y, Takebayashi S. Mesangial IgA2 deposits and lectin pathway-mediated complement activation in IgA glomerulonephritis. Am J Kidney Dis. 2001;38:1082–88.CrossRefPubMed Hisano S, Matsushita M, Fujita T, Endo Y, Takebayashi S. Mesangial IgA2 deposits and lectin pathway-mediated complement activation in IgA glomerulonephritis. Am J Kidney Dis. 2001;38:1082–88.CrossRefPubMed
28.
Zurück zum Zitat Matsushita M, Fujita T. Ficolins and the lectin complement pathway. Immunol Rev. 2001;180:78–85.CrossRefPubMed Matsushita M, Fujita T. Ficolins and the lectin complement pathway. Immunol Rev. 2001;180:78–85.CrossRefPubMed
29.
Zurück zum Zitat Dahl MR, Thiel M, Matsushita T, Fujita T, Willis A, Christensen T, et al. MASP-3 and its association with distinct complexes of the mannan-binding lectin complement activation pathway. Immunity. 2001;15:127–35.CrossRefPubMed Dahl MR, Thiel M, Matsushita T, Fujita T, Willis A, Christensen T, et al. MASP-3 and its association with distinct complexes of the mannan-binding lectin complement activation pathway. Immunity. 2001;15:127–35.CrossRefPubMed
30.
Zurück zum Zitat Matsushita M, Endo Y, Fujita T. Complement-activating complex of ficolin and mannose-binding lectin-associated serine protease. J Immunol. 2000;164:2281–4.PubMed Matsushita M, Endo Y, Fujita T. Complement-activating complex of ficolin and mannose-binding lectin-associated serine protease. J Immunol. 2000;164:2281–4.PubMed
31.
Zurück zum Zitat Roos A, Rastaldi MP, Calvaresi N. Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease. J Am Soc Nephrol. 2006;17:1724–34.CrossRefPubMed Roos A, Rastaldi MP, Calvaresi N. Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease. J Am Soc Nephrol. 2006;17:1724–34.CrossRefPubMed
32.
Zurück zum Zitat Nauta AJ, Raaschou-Jensen N, Roos A, Daha MR, Madsen HO, Borrias-Essers MC, et al. Mannose-binding lectin engagement with late apoptotic and necrotic cells. Eur J Immunol. 2003;33:2853–63.CrossRefPubMed Nauta AJ, Raaschou-Jensen N, Roos A, Daha MR, Madsen HO, Borrias-Essers MC, et al. Mannose-binding lectin engagement with late apoptotic and necrotic cells. Eur J Immunol. 2003;33:2853–63.CrossRefPubMed
33.
Zurück zum Zitat Colvin RB. Antibody-mediated renal allograft rejection: diagnosis and pathogenesis. J Am Soc Nephrol. 2007;18:1046–56.CrossRefPubMed Colvin RB. Antibody-mediated renal allograft rejection: diagnosis and pathogenesis. J Am Soc Nephrol. 2007;18:1046–56.CrossRefPubMed
34.
Zurück zum Zitat Cohen D, Koopmans M, Kremer Hovinga IC, Berger SP, van Roos Groningen M, Steup-Beekman GM, et al. Potential for glomerular C4d as an indicator of thrombotic microangiopathy in lupus nephritis. Arthritis Rheum. 2008;58:2460–9.CrossRefPubMed Cohen D, Koopmans M, Kremer Hovinga IC, Berger SP, van Roos Groningen M, Steup-Beekman GM, et al. Potential for glomerular C4d as an indicator of thrombotic microangiopathy in lupus nephritis. Arthritis Rheum. 2008;58:2460–9.CrossRefPubMed
35.
Zurück zum Zitat Ohsawa I, Ohi H, Endo M, Fujita T, Matsushita M, Fujita T. Evidence of lectin complement pathway activation in poststreptococcal glomerulonephritis. Kidney Int. 1999;56:1158–60.CrossRefPubMed Ohsawa I, Ohi H, Endo M, Fujita T, Matsushita M, Fujita T. Evidence of lectin complement pathway activation in poststreptococcal glomerulonephritis. Kidney Int. 1999;56:1158–60.CrossRefPubMed
36.
Zurück zum Zitat Hisano S, Matsushita M, Fujita T, Iwasaki H. Activation of the lectin complement pathway in Henoch–Schonlein purpura nephritis. Am J Kidney Dis. 2005;45:295–302.CrossRefPubMed Hisano S, Matsushita M, Fujita T, Iwasaki H. Activation of the lectin complement pathway in Henoch–Schonlein purpura nephritis. Am J Kidney Dis. 2005;45:295–302.CrossRefPubMed
37.
Zurück zum Zitat European Vasculitis Study Group (EUVAS), de Lind Van Wijngaarden RAF, Hauer HA, Wolterbeek R, Jayne DRW, Rasmussen GN, et al. Clinical and histologic determinants of renal outcome in ANCA-associated vasculitis: a prospective analysis of 100 patients with severe renal involvement. J Am Soc Nephrol. 2006;17:2264–74.CrossRefPubMed European Vasculitis Study Group (EUVAS), de Lind Van Wijngaarden RAF, Hauer HA, Wolterbeek R, Jayne DRW, Rasmussen GN, et al. Clinical and histologic determinants of renal outcome in ANCA-associated vasculitis: a prospective analysis of 100 patients with severe renal involvement. J Am Soc Nephrol. 2006;17:2264–74.CrossRefPubMed
38.
Zurück zum Zitat Seelen MA, Roos A, Daha MR. Role of complement in innate and autoimmunity. J Nephrol. 2005;18:642–53.PubMed Seelen MA, Roos A, Daha MR. Role of complement in innate and autoimmunity. J Nephrol. 2005;18:642–53.PubMed
Metadaten
Titel
Differential Deposition of C4d and MBL in Glomeruli of Patients with ANCA-Negative Pauci-Immune Crescentic Glomerulonephritis
verfasst von
Guang-qun Xing
Min Chen
Gang Liu
Xin Zheng
Jie E
Ming-hui Zhao
Publikationsdatum
01.01.2010
Verlag
Springer US
Erschienen in
Journal of Clinical Immunology / Ausgabe 1/2010
Print ISSN: 0271-9142
Elektronische ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-009-9344-2

Weitere Artikel der Ausgabe 1/2010

Journal of Clinical Immunology 1/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Perioperative Checkpointhemmer-Therapie verbessert NSCLC-Prognose

28.05.2024 NSCLC Nachrichten

Eine perioperative Therapie mit Nivolumab reduziert das Risiko für Rezidive und Todesfälle bei operablem NSCLC im Vergleich zu einer alleinigen neoadjuvanten Chemotherapie um über 40%. Darauf deuten die Resultate der Phase-3-Studie CheckMate 77T.

Positiver FIT: Die Ursache liegt nicht immer im Dickdarm

27.05.2024 Blut im Stuhl Nachrichten

Immunchemischer Stuhltest positiv, Koloskopie negativ – in solchen Fällen kann die Blutungsquelle auch weiter proximal sitzen. Ein Forschungsteam hat nachgesehen, wie häufig und in welchen Lokalisationen das der Fall ist.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.